KOSDAQ · Healthcare · ₩192B
₩7,920-3.77%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.2% · as of 26.10.27
Among 37 신약 개발 peers
Quarterly Revenue Growth
“이번 분기는 기술이전 성과가 다음 임상으로 이어지는지 확인하는 때입니다.”
In the company's words · 2026 2분기 filing